Statements (72)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:disease
|
gptkbp:affects |
gastrointestinal tract
any part of the gastrointestinal tract |
gptkbp:associated_with |
environmental factors
genetic factors immune system dysfunction |
gptkbp:can_cause |
gptkb:anemia
joint pain dehydration skin problems vitamin deficiencies mouth sores eye inflammation perianal disease |
gptkbp:can_lead_to |
hospitalization
colon cancer surgery for complications |
gptkbp:cause |
inflammation
|
gptkbp:complications |
malnutrition
intestinal obstruction fistulas |
gptkbp:diagnosis |
physical examination
endoscopy medical history imaging tests |
gptkbp:first_described_by |
gptkb:1932
|
https://www.w3.org/2000/01/rdf-schema#label |
Crohn's disease
|
gptkbp:is_a_chronic_condition |
gptkb:true
|
gptkbp:is_associated_with |
increased risk of blood clots
increased risk of liver disease increased risk of osteoporosis |
gptkbp:is_characterized_by |
chronic inflammation
skip lesions |
gptkbp:is_common_in |
gptkb:people_of_Ashkenazi_Jewish_descent
young adults |
gptkbp:is_less_prevalent_in |
gptkb:Africa
gptkb:Asia |
gptkbp:is_managed_by |
lifestyle changes
stress management dietary modifications |
gptkbp:is_monitored_by |
blood tests
imaging studies regular check-ups |
gptkbp:is_often_seen_in |
gptkb:Europe
gptkb:ulcerative_colitis gptkb:North_America |
gptkbp:named_after |
gptkb:Burrill_Crohn
|
gptkbp:prevalence |
1.6 million people in the US
|
gptkbp:scientific_classification |
a type of inflammatory bowel disease
|
gptkbp:symptoms |
fatigue
weight loss abdominal pain diarrhea |
gptkbp:treatment |
gptkb:surgery
antibiotics nutritional support biologics corticosteroids anti-inflammatory drugs immunosuppressants clinical trials for new therapies |
gptkbp:bfsParent |
gptkb:Celiac_Disease
gptkb:cyclosporine gptkb:Humira gptkb:Stelara gptkb:Rituximab gptkb:Remicade gptkb:Skyrizi gptkb:interferon-gamma gptkb:Immunex_Corporation gptkb:rituximab |
gptkbp:bfsLayer |
5
|